×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Neuropathology Market Analysis

ID: MRFR/Pharma/3543-HCR
100 Pages
Rahul Gotadki
October 2025

Neuropathology Market Research Report By Diagnosis (Biopsy, Body Fluids, Peripheral Blood Smears, others), Application (Cerebral Hypoxia & Stroke, Perinatal Disorders, CNS Infections, Demyelinative Diseases, others), End User– Global Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Neuropathology Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Analysis

In-depth Analysis of Neuropathology Market Industry Landscape

The neuropathology market is changing fast because of things that affect how brain disorders are diagnosed, treated, and studied. To get around in neuropathology's constantly changing world, stakeholders need to understand how markets work. The rise in brain diseases drives neuropathology. More individuals are acquiring Alzheimer's, Parkinson's, and other neuropathies, requiring diagnosis and treatment. Neuropathology is evolving rapidly due to new imaging and diagnosing technologies. More sensitive and accurate testing technologies are needed to enhance brain disease diagnosis and categorization. This affects treatment choices and patient outcomes. Neurological illness treatments change often, affecting the market. New gene therapies, neurostimulation, and standard medication techniques are adding interest. How effectively and broadly these new treatments are received determines pharmaceutical and biotechnology companies' market competitiveness. Neuropathology sales are being affected by the shift toward precision medicine. Treatment plans that are tailored to each patient and take genetic and biological factors into account are working better and better. This personalized approach leads to more efficient and focused treatments, which changes the way the market works. Neuropathology study is a big part of what drives the market. New drugs and treatments, as well as a better knowledge of diseases, drive innovation and market growth. It is normal for businesses and universities to work together, which helps the area grow. The market for neuropathology is moving toward care that is focused on the patient. More and more, patient desires, quality of life, and experience are being taken into account when making therapy choices. This change has an impact on states, healthcare workers, and drug companies, changing the way the market works. The neuropathology market is affected by many things, such as how easy it is to get to and use modern healthcare facilities. Market growth is driven by places with good healthcare and study systems. Market possibilities may be affected by the facilities of healthcare. Neuropathology is affected by a number of economic problems. Costs of health care and rules about compensation are two examples. The prices of diagnostic tests, drugs, and therapeutic treatments affect how easy it is for patients to get them and how many choices doctors have. Regulation of the industry has a big impact on the neuropathology market. Medical device approvals, diagnostic tests, and treatment methods are closely regulated, which affects how these companies develop and sell their products. Changes to the rules may make it harder to get into a market or compete with others. The neuropathology market is also growing because the healthcare industry is becoming more global. Businesses are looking for new customers in different places because of changes in how often people get sick, how healthcare is provided, and the types of people who get sick. Globalization changes how markets are penetrated and how local healthcare options work.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

At what CAGR is the neuropathology market projected to grow during the forecast period?

Neuropathology market is projected to grow at a 8.14% CAGR between 2024- 2032.

Which region is expected to dominate the neuropathology market?

North America is expected to dominate the neuropathology market.

Name the major end users of the neuropathology market.

Research centers, clinics, hospitals, and others are the major end users of the neuropathology market.

What are the key factors driving the neuropathology market?

Technological advances in medical diagnostic devices and rising prevalence of musculoskeletal conditions are the key factors driving the neuropathology market.

Who are the leading players profiled in the neuropathology market?

Leading players profiled in the neuropathology market include NeoGenomics Laboratories, Agilent Technologies Inc., Quest Diagnostics Incorporated, Danaher Corporation, Sakura Finetek USA Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Therapath LLC, and ARUP Laboratories.

Market Summary

As per Market Research Future Analysis, the Neuropathology Market was valued at USD 2.79 Billion in 2023 and is projected to grow to USD 7.74 Billion by 2032, with a CAGR of 8.14% from 2024 to 2032. The market is driven by the rising incidence of musculoskeletal conditions and advancements in medical diagnostic devices. Neuropathologists play a crucial role in diagnosing diseases through biopsy examinations, particularly for cerebrovascular disorders. The introduction of less invasive tests like epidermal nerve fiber density testing (ENFD) is enhancing diagnostic capabilities. The market is segmented by diagnostic tests, applications, and end-users, with significant growth observed in hospitals and research centers. North America leads the market due to high healthcare expenditure and advanced infrastructure, followed by Europe and the rapidly growing Asia Pacific region.

Key Market Trends & Highlights

The Neuropathology Market is witnessing significant growth driven by technological advancements and increasing disease prevalence.

  • Market Size in 2023: USD 2.79 Billion. Projected Market Size by 2032: USD 7.74 Billion. CAGR from 2024 to 2032: 8.14%. North America holds the largest market share due to advanced healthcare infrastructure.

Market Size & Forecast

2023 Market Size USD 2.79 Billion
2024 Projected Market Size USD 3.26 Billion
2032 Projected Market Size USD 7.74 Billion
CAGR (2024-2032) 8.14%.

Major Players

<p>Key players include <a href="https://ltd.aruplab.com/Tests/Pub/2013262">ARUP Laboratories</a>, Therapath LLC, Abbott Laboratories, Laboratory Corporation of America Holdings, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sakura Finetek USA Inc., Danaher Corporation, Quest Diagnostics Incorporated, Agilent Technologies Inc., and NeoGenomics Laboratories.</p>

Market Trends

Neuropathology Market Market Drivers

Aging Population

The aging population is a critical factor influencing the Global Neuropathology Market Industry. As life expectancy increases globally, the proportion of elderly individuals is rising, leading to a higher incidence of age-related neurological disorders. This demographic shift is prompting healthcare systems to adapt and expand their services to meet the needs of this population. For example, countries with rapidly aging populations are witnessing a surge in demand for neuropathological assessments and interventions. Consequently, the Global Neuropathology Market Industry is expected to grow substantially, with estimates suggesting it will reach 3.26 USD Billion in 2024, reflecting the urgent need for specialized care.

Market Growth Projections

The Global Neuropathology Market Industry is anticipated to experience robust growth over the next decade. Projections indicate that the market will expand from 3.26 USD Billion in 2024 to an impressive 9.79 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 10.51% from 2025 to 2035. Factors contributing to this expansion include advancements in diagnostic technologies, increasing prevalence of neurological disorders, and heightened research funding. The market's evolution is likely to be shaped by ongoing innovations and a growing emphasis on personalized medicine, which may further enhance the efficacy of neuropathological interventions.

Increased Research Funding

The surge in research funding from both public and private sectors is significantly impacting the Global Neuropathology Market Industry. Governments and organizations are increasingly investing in research initiatives aimed at understanding the complexities of neurological diseases. For instance, the National Institutes of Health (NIH) has allocated substantial resources to research on neurodegenerative disorders. This influx of funding not only supports the development of new diagnostic and therapeutic approaches but also fosters collaboration among researchers and institutions. As a result, the Global Neuropathology Market Industry is likely to benefit from enhanced innovation and discovery, contributing to its projected growth to 9.79 USD Billion by 2035.

Growing Awareness and Education

There is a growing awareness and education regarding neurological disorders among healthcare professionals and the general public, which is driving the Global Neuropathology Market Industry. Initiatives aimed at educating clinicians about the latest advancements in neuropathology are becoming more prevalent. Additionally, public health campaigns are raising awareness about the importance of early diagnosis and treatment of neurological conditions. This increased knowledge is likely to lead to higher demand for neuropathological services and products. As a result, the Global Neuropathology Market Industry is poised for growth, with projections indicating a significant expansion in the coming years.

Rising Prevalence of Neurological Disorders

The increasing incidence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, is a primary driver of the Global Neuropathology Market Industry. As the global population ages, the prevalence of these conditions is expected to rise significantly. For instance, it is estimated that by 2035, the number of individuals suffering from dementia will reach 115 million worldwide. This growing patient population necessitates advanced diagnostic and therapeutic solutions, thereby propelling the market forward. The Global Neuropathology Market Industry is projected to reach 3.26 USD Billion in 2024, reflecting the urgent need for innovative neuropathological assessments.

Technological Advancements in Diagnostic Tools

Technological innovations in diagnostic tools, such as advanced imaging techniques and molecular pathology, are transforming the landscape of the Global Neuropathology Market Industry. These advancements enhance the accuracy and speed of diagnoses, allowing for earlier intervention and improved patient outcomes. For example, the integration of artificial intelligence in imaging analysis is showing promise in identifying subtle changes in brain pathology. As these technologies become more widely adopted, they are likely to drive market growth. The Global Neuropathology Market Industry is expected to experience a compound annual growth rate of 10.51% from 2025 to 2035, indicating a robust demand for cutting-edge diagnostic solutions.

Market Segment Insights

Regional Insights

Key Companies in the Neuropathology Market market include

Industry Developments

Future Outlook

Neuropathology Market Future Outlook

<p>The Neuropathology Market is poised for growth at a 10.51% CAGR from 2024 to 2035, driven by advancements in diagnostic technologies and increasing prevalence of neurological disorders.</p>

New opportunities lie in:

  • <p>Invest in AI-driven diagnostic tools to enhance accuracy and efficiency. Develop targeted therapies for neurodegenerative diseases to capture emerging patient needs. Expand global partnerships for research collaborations in neuropathology innovations.</p>

<p>By 2035, the Neuropathology Market is expected to exhibit robust growth, reflecting advancements and increased demand.</p>

Market Segmentation

Report Scope

{}

FAQs

At what CAGR is the neuropathology market projected to grow during the forecast period?

Neuropathology market is projected to grow at a 8.14% CAGR between 2024- 2032.

Which region is expected to dominate the neuropathology market?

North America is expected to dominate the neuropathology market.

Name the major end users of the neuropathology market.

Research centers, clinics, hospitals, and others are the major end users of the neuropathology market.

What are the key factors driving the neuropathology market?

Technological advances in medical diagnostic devices and rising prevalence of musculoskeletal conditions are the key factors driving the neuropathology market.

Who are the leading players profiled in the neuropathology market?

Leading players profiled in the neuropathology market include NeoGenomics Laboratories, Agilent Technologies Inc., Quest Diagnostics Incorporated, Danaher Corporation, Sakura Finetek USA Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Therapath LLC, and ARUP Laboratories.

  1. Definition
    1. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
    2. Introduction
    3. Primary Research
    4. Secondary research
    5. Market Size Estimation
    6. Drivers
    7. Restrains
    8. Opportunities
    9. Challenges
    10. Macroeconomic Indicators
    11. Technology Trends & Assessment
    12. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    13. Value Chain Analysis
    14. Investment Feasibility Analysis
    15. Pricing Analysis
  2. Chapter 6. Global Neuropathology Market, by Diagnosis Test
    1. Introduction
    2. Biopsy
      1. Market Estimates & Forecast, 2020 – 2027
    3. Body fluids
      1. Market Estimates & Forecast, 2020 – 2027
    4. Peripheral blood smears
      1. Market Estimates & Forecast, 2020 – 2027
    5. Biopsy
      1. Market Estimates & Forecast, 2020 – 2027
    6. Tissue resections
      1. Market Estimates & Forecast, 2020 – 2027
    7. Others
      1. Market Estimates & Forecast, 2020 – 2027
  3. Chapter 7. Global Neuropathology Market, by Application
    1. Introduction
    2. Cerebral hypoxia and stroke
      1. Market Estimates & Forecast, 2020 – 2027
    3. Perinatal disorders
      1. Market Estimates & Forecast, 2020 – 2027
    4. CNS infections
      1. Market Estimates & Forecast, 2020 – 2027
    5. Demyelinative diseases
      1. Market Estimates & Forecast, 2020 – 2027
    6. Brain tumors
      1. Market Estimates & Forecast, 2020 – 2027
    7. Neurodegenerative diseases
      1. Market Estimates & Forecast, 2020 – 2027
    8. Inherited metabolic disorders
      1. Market Estimates & Forecast, 2020 – 2027
    9. Peripheral neuropathy
      1. Market Estimates & Forecast, 2020 – 2027
    10. Myopathology
      1. Market Estimates & Forecast, 2020 – 2027
    11. Others
  4. Chapter 8. Global Neuropathology Market, by End User
    1. Introduction
    2. Hospitals
      1. Market Estimates & Forecast, 2020 – 2027
    3. Clinics
      1. Market Estimates & Forecast, 2020 – 2027
    4. Research centers
      1. Market Estimates & Forecast, 2020 – 2027
    5. Others
      1. Market Estimates & Forecast, 2020 – 2027
  5. Chapter .9 Global Neuropathology Market, by Region
    1. Introduction
    2. Americas
      1. North America
      2. South America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. Republic of Korea
      6. Rest of Asia Pacific
    5. The Middle East & Africa
      1. United Arab Emirates
      2. Saudi Arabia
      3. Rest of the Middle East & Africa
    6. Chapter 10 Company Landscape
    7. Introduction
    8. Market Share Analysis
    9. Key Development & Strategies
      1. Key Developments
    10. Chapter 11 Company Profiles
    11. Abbott Laboratories
      1. Company Overview
      2. Product Overview
      3. Financials
      4. SWOT Analysis
    12. Therapath LLC
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    13. ARUP Laboratories
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    14. Laboratory Corporation of America Holdings
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    15. F. Hoffmann-La Roche Ltd
      1. Company Overview
      2. Product Overview
      3. Financial overview
      4. Key Developments
    16. Danaher Corporation
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
    17. Quest Diagnostics Incorporated
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    18. NeoGenomics Laboratories
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    19. Agilent Technologies Inc.
      1. Company Overview
      2. Product Overview
      3. Financial overview
      4. Key Developments
    20. Others
    21. Chapter 12 MRFR Conclusion
    22. Key Findings
      1. From CEO’s View Point
      2. Unmet Needs of the Market
    23. Key Companies to Watch
    24. Prediction of Pharmaceutical industry
    25. Chapter 13 Appendix
  6. LIST OF TABLES
  7. Neuropathology Industry Synopsis, 2020 – 2027
  8. Neuropathology Market Estimates and Forecast, 2020 – 2027, (USD Million)
  9. Neuropathology Market by Region, 2020 – 2027, (USD Million)
  10. Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  11. Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  12. Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  13. North America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  14. North America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  15. North America Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  16. US Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  17. US Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  18. US Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  19. Canada Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  20. Canada Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  21. Canada Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  22. South America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  23. South America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  24. South America Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  25. Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  26. Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  27. Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  28. Western Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  29. Western Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  30. Western Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  31. Eastern Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  32. Eastern Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  33. Eastern Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  34. Asia Pacific Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  35. Asia Pacific Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  36. Asia Pacific Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  37. Middle East & Africa Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  38. Middle East & Africa Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  39. Middle East & Africa Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  40. LIST OF FIGURES
  41. Research Process
  42. Segmentation for Neuropathology Market
  43. Segmentation Market Dynamics for Neuropathology Market
  44. Global Neuropathology Market Share, by Diagnosis 2020
  45. Global Neuropathology Market Share, by Treatment 2020
  46. Global Neuropathology Market Share, by End Users, 2020
  47. Global Neuropathology Market Share, by Region, 2020
  48. North America Neuropathology Market Share, by Country, 2020
  49. Europe Neuropathology Market Share, by Country, 2020
  50. Asia Pacific Neuropathology Market Share, by Country, 2020
  51. Middle East & Africa Neuropathology Market Share, by Country, 2020
  52. Global Neuropathology Market: Company Share Analysis, 2020 (%)
  53. Abbott Laboratories.: Key Financials
  54. Abbott Laboratories, Inc.: Segmental Revenue
  55. Abbott Laboratories.: Geographical Revenue
  56. Therapath LLC: Key Financials
  57. Therapath LLC: Segmental Revenue
  58. Therapath LLC: Geographical Revenue
  59. ARUP Laboratories: Key Financials
  60. ARUP Laboratories: Segmental Revenue
  61. ARUP Laboratories: Geographical Revenue
  62. Laboratory Corporation of America Holdings: Key Financials
  63. Laboratory Corporation of America Holdings: Segmental Revenue
  64. Laboratory Corporation of America Holdings: Geographical Revenue
  65. F. Hoffmann-La Roche Ltd: Key Financials
  66. F. Hoffmann-La Roche Ltd: Segmental Revenue
  67. F. Hoffmann-La Roche Ltd: Geographical Revenue
  68. Danaher Corporation: Key Financials
  69. Danaher Corporation: Segmental Revenue
  70. Danaher Corporation: Geographical Revenue
  71. Quest Diagnostics Incorporated: Key Financials
  72. Quest Diagnostics Incorporated: Segmental Revenue
  73. Quest Diagnostics Incorporated: Geographical Revenue
  74. NeoGenomics Laboratories: Key Financials
  75. NeoGenomics Laboratories: Segmental Revenue
  76. NeoGenomics Laboratories: Geographical Revenue
  77. Agilent Technologies Inc: Key Financials
  78. Agilent Technologies Inc: Segmental Revenue
  79. Agilent Technologies Inc: Geographical Revenue

Neuropathology Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓